52w high/low | ₹4245.5 / ₹2198.15 |
P/E ratio | 58.3 |
Dividend | 0.59 |
ROE | 21.01 |
ROCE | 26.93 |
Face value | 10 |
Book value | ₹248.17Cr |
Market capital | ₹25,412.35Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr. Lal PathLabs has built a national, 'hub and spoke' network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 214 other clinical laboratories, 3095 patient service centers and 6995 pickup points as of 31 March 2020. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The catalogue of services includes 455 test panels, 2537 pathology tests and 1961 radiology and cardiology tests. Late Dr.